Semax Vs Selank: A Research Comparison

Semax and Selank are synthetic regulatory peptides with distinct structures, origins, and neurobiological research profiles. Semax is a synthetic ACTH(4-7)-derived heptapeptide studied primarily in neurotrophic and cognitive signaling, while Selank is a synthetic tuftsin-derived heptapeptide investigated in anxiolytic, GABAergic, and immune-related pathways. Their differences involve BDNF and NGF expression, monoamine signaling, GABAergic neurotransmission, neuroplasticity, neuroprotection, stress responses, cognition, memory, anxiety-related behavior, and neuroimmune regulation, making them distinct models for neuroscience, neuropharmacology, and peptide signaling research.

Key Difference

• Peptide structure: Semax is a 7-amino-acid peptide with the sequence MEHFPGP; Selank is a 7-amino-acid peptide with the sequence TKPRPGP.
• Molecular origin: Semax is derived from the ACTH(4–7) fragment of adrenocorticotropic hormone; Selank is derived from tuftsin, an endogenous immunomodulatory tetrapeptide.
• Shared modification: Both peptides contain a C-terminal Pro-Gly-Pro (PGP) extension, but their biologically distinct ACTH-derived MEHF and tuftsin-derived TKPR regions give them different pharmacological research profiles.
• Primary mechanism: Semax is more strongly associated with neurotrophic-factor regulation, including BDNF, NGF, and Trk signaling; Selank is more strongly associated with GABAergic neurotransmission, broader neurotransmitter regulation, and neuroimmune signaling.
• Neurotransmitter effects: Semax research particularly involves dopamine and serotonin signaling and monoamine metabolism; Selank research emphasizes GABAergic regulation alongside serotonergic, dopaminergic, and other neurotransmitter-related pathways.
• Gene-expression effects: Semax has demonstrated changes in genes involved in neurotrophic signaling, neuronal plasticity, vascular responses, and neuroprotection; Selank has demonstrated broader transcriptional effects involving neurotransmitter receptors, ion channels, immune signaling, and nervous-system regulation.
• Neuroprotection vs stress regulation: Semax is particularly investigated in cerebral ischemia, neuronal injury, oxidative stress, cognition, and neuroprotection; Selank is more closely associated with anxiety-related behavior, stress adaptation, emotional regulation, and anxiolytic research.
• Neuroimmune activity: Selank has a distinctive connection to immunomodulation and cytokine signaling because of its tuftsin-derived structure; Semax’s immune-related effects are more commonly investigated within neuroprotection, ischemia, and neuronal stress models.
• Research focus: Semax primarily provides a model for BDNF/NGF signaling, neuroplasticity, cognition, memory, neuroprotection, and cerebral ischemia, while Selank provides a model for GABAergic signaling, anxiety and stress responses, neuroimmune regulation, and neurotransmitter homeostasis.

What Is Semax?

Semax is a synthetic heptapeptide derived from the ACTH(4–7) fragment of adrenocorticotropic hormone (ACTH), with the sequence Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP). Unlike full-length ACTH, Semax is studied primarily for central nervous system activity rather than melanocortin-mediated adrenal effects, with research examining neurotrophic signaling, gene expression, monoamine systems, and neuroplasticity.

Semax is extensively studied in BDNF and NGF regulation, neuroprotection, synaptic plasticity, dopaminergic and serotonergic signaling, cognition, learning, memory, oxidative stress, cerebral ischemia, neuronal survival, and neuropharmacology.

What Is Selank?

Selank is a synthetic heptapeptide derived from tuftsin, a naturally occurring immunomodulatory tetrapeptide, with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP). Unlike Semax, which is primarily studied for neurotrophic and cognitive signaling, Selank is investigated for its effects on GABAergic neurotransmission, neuroimmune regulation, stress-response pathways, and anxiety-related behavior.

Selank is extensively studied in GABAergic signaling, anxiolytic mechanisms, neuroimmune modulation, cytokine regulation, serotonergic and dopaminergic neurotransmission, stress adaptation, emotional behavior, cognitive function, memory processes, neuroplasticity, and neuropharmacology.

Molecular Structure & Modifications

1. Amino-Acid Sequence & Peptide Structure

• Semax: 7-amino-acid heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP).
• Selank: 7-amino-acid heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP).

Both are synthetic heptapeptides, but their different N-terminal sequences reflect different parent peptides and biological research profiles.

2. Parent Peptide & Molecular Origin

• Semax: Derived from the ACTH(4–7) sequence Met-Glu-His-Phe (MEHF), corresponding to a fragment of adrenocorticotropic hormone (ACTH).
• Selank: Derived from the immunomodulatory peptide tuftsin, whose sequence is Thr-Lys-Pro-Arg (TKPR).

This gives Semax an ACTH/melanocortin-related structural origin, whereas Selank has a tuftsin/immunoregulatory origin.

3. C-Terminal Pro-Gly-Pro Modification

Both Semax and Selank contain the C-terminal tripeptide Pro-Gly-Pro (PGP).

• Semax: ACTH(4–7) + Pro-Gly-Pro → MEHFPGP.
• Selank: Tuftsin + Pro-Gly-Pro → TKPRPGP.

The addition of PGP contributes to increased resistance to enzymatic degradation compared with their shorter parent fragments and is an important structural feature of both synthetic peptides.

4. Shared Structure, Different Functional Domains

Despite both containing seven amino acids and the same C-terminal PGP sequence, their first four residues are completely different.

• Semax: MEHF sequence originates from ACTH(4–7) and is associated with neurotrophic, neuroprotective, and neuromodulatory research.
• Selank: TKPR sequence originates from tuftsin and is associated with neuroimmune, anxiolytic, and neurotransmitter-related research.

The different N-terminal domains therefore distinguish the two peptides despite their shared PGP extension.

5. Proteolytic Stability

The Pro-Gly-Pro extension was incorporated into both peptides to improve peptide stability and prolong biological activity compared with the shorter ACTH(4–7) and tuftsin fragments. Their proline-rich C-terminal regions can influence susceptibility to peptidases and the formation of biologically active peptide fragments during degradation.

6. Molecular Weight

Semax has a molecular weight of approximately 813.9 Da, while Selank has a molecular weight of approximately 751.9 Da.

Although both are small heptapeptides of similar length, their different amino-acid composition produces distinct molecular masses, physicochemical properties, peptide metabolites, and biological activity.

7. Structural Basis of Their Research Differences

Semax and Selank demonstrate how two peptides with the same length and shared PGP sequence can exhibit substantially different research profiles.

Semax: ACTH(4–7)-derived structure → neurotrophic signaling, BDNF/NGF regulation, monoamine signaling, neuroprotection, and neuroplasticity research.

Selank: Tuftsin-derived structure → GABAergic signaling, neuroimmune regulation, stress-response, anxiolytic, and cytokine research.

Their primary structural difference is therefore the ACTH-derived MEHF domain of Semax versus the tuftsin-derived TKPR domain of Selank, while both share the stabilizing Pro-Gly-Pro C-terminal sequence.

Mechanism of Actions Difference

1. Primary Mechanistic Difference

Semax and Selank do not have a single clearly established receptor target. Instead, research suggests that they influence multiple neuronal signaling and gene-expression pathways.

Semax

• Primarily associated with neurotrophic and neuroprotective signaling
• Modulates BDNF and NGF expression
• Influences dopaminergic and serotonergic neurotransmission
• Studied for neuroplasticity, neuronal survival, and cognitive processes

Selank

• Primarily associated with GABAergic and neuroimmune signaling
• Modulates GABA-related neurotransmission
• Influences serotonin and other monoamine systems
• Studied for stress responses, anxiety-related behavior, and immune regulation

The fundamental difference is Semax’s stronger association with neurotrophic and neuroplasticity pathways versus Selank’s stronger association with GABAergic, stress-response, and neuroimmune pathways.

2. Neurotrophic Signaling

Semax: Research has demonstrated changes in brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) expression, connecting Semax with neuronal survival, synaptic plasticity, learning, memory, and neural adaptation.

Selank: Neuroplasticity-related effects are also investigated, but Selank research places greater emphasis on neurotransmitter regulation and changes in the expression of genes involved in neuronal signaling.

Semax therefore has a more direct research association with BDNF/NGF-mediated neurotrophic signaling.

3. GABAergic Signaling

Semax: GABAergic signaling is not considered its principal characterized mechanism, with research focusing more strongly on neurotrophic factors, monoamines, and neuroprotection.

Selank: GABAergic neurotransmission is a major area of mechanistic research. Studies have investigated changes involving GABA receptor-related systems and their potential relationship with anxiety, stress responses, and neuronal excitability.

This makes Selank particularly relevant to research involving inhibitory neurotransmission and GABAergic regulation.

4. Monoamine Neurotransmission

Both peptides have been investigated for their influence on monoamine neurotransmitter systems, but their research emphasis differs.

Semax: Associated particularly with dopaminergic and serotonergic signaling and changes in monoamine metabolism in brain regions involved in cognition and neural responses.

Selank: Studied for modulation of serotonergic and other monoaminergic systems in connection with stress, anxiety-related behavior, and emotional regulation.

Thus, monoamine signaling represents an area of overlap, while the downstream research contexts differ.

5. Gene-Expression Regulation

Both Semax and Selank have been associated with changes in neuronal gene expression rather than acting solely through one conventional receptor pathway.

Semax: Research has examined expression of genes associated with neurotrophic factors, immune signaling, vascular function, and neuronal plasticity.

Selank: Research has examined genes associated with neurotransmission, GABAergic signaling, immune responses, and nervous-system function.

These transcriptional effects suggest broader regulatory mechanisms involving multiple signaling networks.

6. Neuroimmune & Inflammatory Signaling

Semax: Studied for changes in inflammatory and immune-related signaling, particularly in experimental models involving cerebral ischemia, oxidative stress, and neuronal injury.

Selank: Its tuftsin-derived structure gives it a particularly relevant connection to neuroimmune research, including cytokine regulation, immune signaling, and interactions between nervous and immune systems.

Selank therefore has a stronger structural and research connection to immunomodulatory pathways, whereas Semax is more commonly investigated for neuroprotection during neuronal stress and injury.

7. Neuroprotection vs Stress-Response Regulation

Semax: Research focuses strongly on neuroprotection, neuronal survival, cerebral ischemia, oxidative stress, neuroplasticity, and recovery-related signaling.

Selank: Research focuses more strongly on anxiety-related behavior, stress adaptation, emotional regulation, inhibitory neurotransmission, and neuroimmune signaling.

This produces one of the clearest functional distinctions between the two peptides: Semax is predominantly investigated as a neurotrophic and neuroprotective peptide, while Selank is predominantly investigated as an anxiolytic and neuroregulatory peptide.

Core Research Applications Difference

1. Neuroplasticity & Neurotrophic Research

Semax is particularly studied for neurotrophic signaling involving BDNF, NGF, and their receptor pathways. Research in rat hippocampus found that Semax increased BDNF protein, BDNF gene expression, TrkB expression, and TrkB phosphorylation, linking the peptide to neuroplasticity, synaptic signaling, learning, and memory research.

2. Cognitive & Memory Research

Semax has a stronger research emphasis on cognition, learning, memory formation, and neuronal plasticity. A study examining Semax and BDNF signaling reported increased hippocampal BDNF/TrkB activity alongside increased conditioned avoidance responses, supporting research into the relationship between neurotrophic signaling and cognitive function.

Selank is also investigated in cognitive and nervous-system research, but its literature is more strongly centered on anxiety, stress responses, and neurotransmitter regulation.

3. GABAergic & Anxiolytic Research

Selank is particularly relevant to GABAergic signaling and anxiety-related research. Gene-expression research in rats found that Selank altered the expression of numerous genes involved in neurotransmission, with results supporting a possible relationship with allosteric modulation of the GABAergic system.

Additional cellular research found that Selank modified responses produced by GABA, further supporting investigation of Selank–GABA interactions rather than a simple direct GABA receptor agonist mechanism.

4. Monoamine & Neurotransmitter Research

Both peptides are investigated in neurotransmitter regulation, although their research profiles differ. Semax research in rodents demonstrated modulation of serotonergic activity and enhanced amphetamine-evoked dopamine release, connecting Semax with serotonin, dopamine, and monoamine signaling research.

Selank research encompasses GABAergic, serotonergic, dopaminergic, receptor, transporter, and ion-channel pathways, with gene-expression studies demonstrating broad changes in genes involved in neurotransmission.

5. Neuroprotection & Cerebral Ischemia Research

Semax has substantial experimental research involving neuronal injury, cerebral ischemia, and neuroprotective signaling. In a rat cerebral ischemia model, Semax altered transcription of BDNF, NGF, NT-3, TrkA, and TrkC at different stages following middle cerebral artery occlusion, supporting its use in research into neurotrophic responses to ischemic injury.

This represents a major distinction from Selank, whose research is more heavily concentrated on stress, anxiety-related behavior, GABAergic signaling, and neuroimmune regulation.

6. Stress & Anxiety-Related Research

Selank has a stronger research focus on anxiety, stress adaptation, and emotional regulation. A clinical study involving 62 subjects compared Selank with medazepam in generalized anxiety disorder and neurasthenia and reported similar anxiolytic effects, while also examining enkephalin activity and anxiety-related physiological responses.

Semax, by comparison, is more commonly investigated in cognitive, neurotrophic, neuroprotective, and neuronal-injury research.

7. Neuroimmune & Cytokine Research

Selank’s tuftsin-derived structure makes neuroimmune and immunomodulatory signaling another important area of research. Research examining Selank and cytokine regulation reported changes involving IL-6 and the Th1/Th2 cytokine balance, connecting Selank with immune signaling and interactions between the nervous and immune systems.

Semax also influences immune- and stress-related gene expression, but its research literature places greater emphasis on neurotrophic and neuroprotective pathways.

8. BDNF & NGF Gene-Expression Research

Semax is especially well characterized for rapid, region-dependent changes in neurotrophin expression. Research examining BDNF and NGF expression found time-dependent changes in both genes within the rat hippocampus and frontal cortex following Semax administration.

Earlier cell-culture research also found substantial increases in BDNF and NGF mRNA in rat basal-forebrain glial cells, further supporting Semax as a model for studying neurotrophin regulation and neuronal signaling.